EP 0559755 A4 19940427 -
Publication
Application
Priority
US 62118890 A 19901130
Abstract (en)
[origin: WO9209278A1] Angiotensin II receptor antagonists having formula (1) which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiontensin II receptor antagonism in mammals.
IPC 1-7
IPC 8 full level
A61K 31/415 (2006.01); A61K 31/4166 (2006.01); A61K 31/42 (2006.01); A61K 31/425 (2006.01); A61K 31/675 (2006.01); A61P 9/00 (2006.01); A61P 9/12 (2006.01); A61P 13/02 (2006.01); A61P 15/00 (2006.01); A61P 27/02 (2006.01); A61P 27/06 (2006.01); A61P 43/00 (2006.01); C07D 233/54 (2006.01); C07D 233/64 (2006.01); C07D 233/68 (2006.01); C07D 233/70 (2006.01); C07D 233/72 (2006.01); C07D 233/76 (2006.01); C07D 233/78 (2006.01); C07D 233/88 (2006.01); C07D 233/90 (2006.01); C07D 233/92 (2006.01); C07D 403/04 (2006.01); C07D 403/06 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 405/06 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 409/06 (2006.01); C07D 409/12 (2006.01); C07D 409/14 (2006.01); C07D 413/06 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 417/06 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01)
CPC (source: EP)
A61P 9/00 (2017.12); A61P 9/12 (2017.12); A61P 13/02 (2017.12); A61P 15/00 (2017.12); A61P 27/02 (2017.12); A61P 27/06 (2017.12); A61P 43/00 (2017.12); C07D 233/64 (2013.01)
Citation (search report)
- No further relevant documents disclosed
- See references of WO 9209278A1
Designated contracting state (EPC)
BE CH DE FR GB IT LI NL
DOCDB simple family (publication)
WO 9209278 A1 19920611; AU 9055391 A 19920625; EP 0559755 A1 19930915; EP 0559755 A4 19940427; JP H06503562 A 19940421
DOCDB simple family (application)
US 9108426 W 19911112; AU 9055391 A 19911112; EP 92900730 A 19911112; JP 50192492 A 19911112